CGTS Corp. Revenue and Competitors

Miami, FL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • CGTS Corp.'s estimated annual revenue is currently $9.4M per year.(i)
  • CGTS Corp.'s estimated revenue per employee is $130,500

Employee Data

  • CGTS Corp. has 72 Employees.(i)
  • CGTS Corp. grew their employee count by -1% last year.

CGTS Corp.'s People

NameTitleEmail/Phone
1
Operations DirectorReveal Email/Phone
2
QA Automation EngineerReveal Email/Phone
3
Líder de DocumentaciónReveal Email/Phone
4
IT Infrastructure EngineerReveal Email/Phone
5
IT Infrastructure EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7M54-19%N/AN/A
#2
$28.7M184-3%$10MN/A
#3
$265.1MN/AN/AN/A
#4
$9.3M71-8%N/AN/A
#5
$20M138-22%N/AN/A
#6
$5.2M4712%$16.8MN/A
#7
$31.6M198-13%N/AN/A
#8
$20M1381%N/AN/A
#9
$11.6M80-10%$7MN/A
#10
$240.4M11849%N/AN/A
Add Company

What Is CGTS Corp.?

CGTS CORP INC. and its affiliated companies are specialized in design and implementation of high complexity technological solutions oriented to specific applications, using state-of-the-art technology, continuous innovation and proven quality in processes and results. The companies that make up the CGTS Corp. group are organized around three fundamental business areas: Intelligent and integrated information systems, biometric solutions and complete solutions on VoIP platform.

keywords:N/A

N/A

Total Funding

72

Number of Employees

$9.4M

Revenue (est)

-1%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CGTS Corp. News

2022-04-13 - Labcorp Enhances Cell and Gene Therapy Development ...

... Inc. (Xcellbio), a leading developer of cell and gene therapy ... CGTs modify a person's genes to treat disease by inactivating or...

2022-04-13 - Korea's GC inks deal to secure US cell and gene therapy ...

... moved to acquire 100% of the shares of BioCentriq, Inc, a US CDMO that designs and develops scalable cell and gene technologies (CGTs).

2022-03-30 - Cell-Gene Therapy Market Emerging Rapidly - Businesskorea

Cell-gene therapeutics (CGTs) are emerging in the biotech industry and an ... Samsung Biologics and Samsung Venture Investment Corp.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.5M72-13%N/A
#2
$7.8M72-28%N/A
#3
$7.8M72-28%N/A
#4
$18.8M727%N/A
#5
$15.9M7211%N/A